Skip to main content
Clinical Trials/ACTRN12613001326785
ACTRN12613001326785
Active, not recruiting
未知

Identification and characterisation of risk factors for sudden cardiac death in chronic kidney disease patients on regular haemodialysis using an implantable cardiac monitor

St Jude Medical0 sites50 target enrollmentDecember 2, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Dialysis
Sponsor
St Jude Medical
Enrollment
50
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 2, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Any CKD patient on haemodialysis
  • 2\. Stable medical therapy for at least one month.
  • 3\. All patients must have no prior history of clinical ventricular tachyarrhythmias (including ventricular fibrillation or cardiac arrest) or syncope.

Exclusion Criteria

  • 1\. Pacemaker or Automatic Implantable Cardioverter\-Defibrillator in\-situ
  • 2\. Unstable angina pectoris
  • 3\. Uncontrolled hypertension.
  • 4\. Known coagulopathy, thrombophilia or contraindications to full systemic anticoagulation
  • with heparin or warfarin (e.g. haemorrhagic stroke, active bleeding, heparin induced
  • thrombocytopenic thrombotic syndrome etc.)
  • 5\. Inability to provide informed consent
  • 6\. Women who are pregnant
  • 7\. Children and/or young people (ie. \<18 years)
  • 8\. Patients experiencing NYHA class IV symptoms and/or LVEF \< 35%

Outcomes

Primary Outcomes

Not specified

Similar Trials